What is Valliscor?
Valliscor operates at the forefront of fluorine chemistry, developing and manufacturing advanced fluorine-based chemicals essential for diverse high-tech sectors including pharmaceuticals, semiconductors, polymers, and specialty industries. Established in 2012, the company utilizes a comprehensive suite of technologies to deliver innovative solutions, such as key starting materials and crosslinkers. With established manufacturing operations in Corvallis and an expanding presence at a new campus in Albany, Oregon, Valliscor prioritizes safety and quality, evidenced by its ISO 9001 certification. Its product portfolio features critical compounds like bromofluoromethane and hexafluoro-1,3-butadiene, positioning it as a key supplier in the advanced materials market.
How much funding has Valliscor raised?
Valliscor has raised a total of $650K across 2 funding rounds:
Debt
$150K
Private Equity
$500K
Debt (2020): $150K with participation from PPP
Private Equity (2025): $500K, investors not publicly disclosed
What's next for Valliscor?
The recent major strategic investment signals a new phase of expansion and technological advancement for Valliscor. This substantial capital infusion, part of its $650K in total funding, is expected to accelerate the company's innovation pipeline and potentially broaden its market reach within the pharmaceutical, semiconductor, and specialty chemical sectors. Valliscor's commitment to safety and quality, coupled with its strategic location and specialized product offerings, positions it for continued growth and leadership in the high-value fluorine chemical market. Future developments will likely focus on scaling production capabilities and exploring new applications for its advanced fluorine compounds.
See full Valliscor company page
